Business Standard

Ipca Laboratories Share Price

Know More
BSENSE

1,540.60-14.40 (-0.93%)

12:48 PM, 13-Dec-2024

1,541.30-19.20 (-1.23%)

12:39 PM, 13-Dec-2024

BSE : 524494

NSE : IPCALAB

Sector : Health care

ISIN Code : INE571A01038

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 13-Dec-2024 | 12:48 PM IST

Market Cap (₹ Cr)

39,085

Traded Value (₹ Cr)

0.50

Volume (Shares)

3,274

Face Value (₹)

1

52-Week High (₹)

1,708.70

52-Week High Date

14-Oct-2024

52-Week Low (₹)

1,042.00

52-Week Low Date

21-Dec-2023

All Time High (₹)

1,708.70

All Time High Date

14-Oct-2024

All Time Low (₹)

2.83

All Time Low Date

18-Sep-2001

Ipca Laboratories Ltd

Ipca Laboratories Limited (IPCA) was incorporated on 19th October 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments. The products of the Company are now sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market.Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA) UK-Medicines and Healthcare produ...
Read More

Ipca Labs. News

Nifty Pharma jumps over 2%: Analysts decode the drivers behind the rally

3 min read

Ipca Labs Q2 results: PAT rises 58% to Rs 229 cr, revenue at Rs 2,355 cr

1 min read

Ipca Labs share price hits new high; Motilal Oswal upgrades stock to 'buy'

3 min read

RBI Policy: Will Bank Nifty fall to 50K or hit 52K today? Key levels here

5 min read

Trent, Dixon, Ipca, Coforge, Akzo Nobel hit record highs; rally up to 8%

4 min read

F&O Insights: Will Bank Nifty see short-covering? Check key levels here

5 min read
More

Ipca Laboratories Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

39,103

EPS - TTM (₹) [C]

26.47

P/E Ratio (X) [C]

58.23

Face Value (₹) 1
Latest Dividend (%)200.00
Latest Dividend Date 27-Nov-2024
Dividend Yield (%) 0.26
Book Value Share (₹) [C]264.10
P/B Ratio (₹) [C]5.84

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
HDFC Mid-Cap Opportunities Fund (G) 2437.52 1,58,01,894 3.20
HDFC Mid-Cap Opportunities Fund (IDCW) 2437.52 1,58,01,894 3.20
HDFC Mid-Cap Opportunities Fund - Direct (IDCW) 2437.52 1,58,01,894 3.20
HDFC Mid-Cap Opportunities Fund - Direct (G) 2437.52 1,58,01,894 3.20
Kotak Emerging Equity Fund (G) 1478.97 95,87,797 2.84
Kotak Emerging Equity Fund (IDCW) 1478.97 95,87,797 2.84
Kotak Emerging Equity Fund - Direct (G) 1478.97 95,87,797 2.84
Kotak Emerging Equity Fund - Direct (IDCW) 1478.97 95,87,797 2.84
DSP Midcap Fund (G) 664.75 43,09,410 3.46
DSP Midcap Fund (IDCW) 664.75 43,09,410 3.46

Load more

Research Reports

DateBrokerActionPrices(₹) Report
01-Oct-2024Share Khan Buy 1,734
16-Aug-2024Share Khan Buy 1,600
13-Nov-2023Prabhudas Lilladher Hold 1,060
21-Feb-2023Sharekhan Hold 909
30-Dec-2022Motilal Oswal Buy 1,000

Stock Strength

Today's Low/High (₹)

1,530.00

1,565.95

Week Low/High (₹)

1,500.00

1,572.00

Month Low/High (₹)

1,470.50

1,622.00

Year Low/High (₹)

1,041.00

1,709.00

All time Low/High (₹)

2.83

1,709.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week0.25%0.20%-0.43-0.52%
1 Month2.20%2.42%4.724.20%
3 Month4.41%4.56%-1.85-3.18%
6 Month28.48%28.46%5.924.92%
1 Year40.20%40.19%16.9217.31%
3 Year51.41%51.43%39.5941.34%

Company Info

Company Information

Executive Chairman : Premchand Godha

Managing Director & CFO : A K Jain

Managing Director & CEO : Pranay Godha

Executive Director : Prashant Godha

Independent Non Exe. Director : Kamal Kishore Seth

Independent Non Exe. Director : Narendra Mairpady

Company Sec. & Compli. Officer : Harish P Kamath

Independent Director : Swati Patankar

Independent Director : Vivek Shiralkar

Registered Office: 48 Kandivli Industrial Estate, Kandivli (West),Mumbai,Maharashtra-400067 Ph: 91-22-66474444

Email:investors@ipca.com ; ipca@ipca.com

URL:http://www.ipca.com

FAQs about Ipca Laboratories Ltd

1. What's the Ipca Laboratories Ltd share price today?
Ipca Laboratories Ltd share price was Rs 1,540.60 at 12:48 PM IST on 13th Dec 2024. Ipca Laboratories Ltd share price was down by 0.93% from the previous closing price of Rs 1,555.00. Ipca Laboratories Ltd share price trend:

  • Last 1 Month: Ipca Laboratories Ltd share price moved up by 2.20% on BSE
  • Last 3 Months: Ipca Laboratories Ltd share price moved up by 4.41% on BSE
  • Last 12 Months: Ipca Laboratories Ltd share price moved up by 40.20% on BSE
  • Last 3 Years: Ipca Laboratories Ltd price moved up by 51.41% on BSE


2. How can I quickly analyse the performance of the Ipca Laboratories Ltd stock?
The performance of the Ipca Laboratories Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 58.23
  • Price to book value ratio is 5.84
  • Dividend yield of 0.26
  • The EPS (trailing 12 months) of the Ipca Laboratories Ltd stock is Rs 26.47


3. What is the market cap of Ipca Laboratories Ltd?
Ipca Laboratories Ltd has a market capitalisation of Rs 39,085 crore.


4. What is Ipca Laboratories Ltd's 52-week high/low share price?
The Ipca Laboratories Ltd’s 52-week high share price is Rs 1,708.70 and 52-week low share price is Rs 1,042.00.


5. Is the Ipca Laboratories Ltd profitable?
On a consolidated basis, Ipca Laboratories Ltd reported a profit of Rs 244.12 crore on a total income of Rs 1,827.94 crore for the quarter ended 2024. For the year ended Sep 2024, Ipca Laboratories Ltd had posted a profit of Rs 245.44 crore on a total income of Rs 2,381.16 crore.


6. Which are Ipca Laboratories Ltd’s peers in the Health care sector?
Ipca Laboratories Ltd’s top 5 peers in the Health care sector are Abbott India, Glenmark Pharma., Biocon, Ipca Labs., Glaxosmi. Pharma, Ajanta Pharma, Piramal Pharma.


7. Who owns how much in Ipca Laboratories Ltd?
Key changes to the Ipca Laboratories Ltd shareholding are as follows:

  • Promoter holding in Ipca Laboratories Ltd has gone up to 46.30 per cent as of Sep 2024 from 46.29 per cent as of Dec 2023.